Clinical Trial of CD19-targeted CAR-T Therapy for Refractory Juvenile Dermatomyositis

NCT06569472 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Juvenile Dermatomyositis

Interventions

BIOLOGICAL: CD19-targetd CAR-T

Sponsor

Chongqing Precision Biotech Co., Ltd